China Cancer Drugs Market, by Drugs (Cytotoxic, Targeted, etc.), Cancer Types(Lung, Stomach, Breast, etc.), by Therapy & Companies

View by Category
About This Presentation
Title:

China Cancer Drugs Market, by Drugs (Cytotoxic, Targeted, etc.), Cancer Types(Lung, Stomach, Breast, etc.), by Therapy & Companies

Description:

For more Info: In China, cancer is a major public health concern. Several factors are responsible for the increasing prevalence of cancer in China such as extensive use of tobacco, unhealthy lifestyle and rising geriatric population. Almost one-third of the world’s lung cancer and nearly half of the liver, stomach and esophageal cases of cancer occur in China. China Cancer Drugs Market is expected to be US$ 30 Billion by the year 2024. – PowerPoint PPT presentation

Number of Views:0

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: China Cancer Drugs Market, by Drugs (Cytotoxic, Targeted, etc.), Cancer Types(Lung, Stomach, Breast, etc.), by Therapy & Companies


1
China Anti Cancer Drugs Market
Category Drugs Pharmaceuticals Market Report
2
China Anti Cancer Drugs Market Analyst View
China Anti Cancer Drugs Market expected to be
US 30 Billion by 2024. Get Free Customization in
this Report Press Release Title China Anti
Cancer Drugs Market expected to be US 30 Billion
by 2024. For more Info  https//www.renub.com/c
hina-anti-cancer-drugs-market-nd.php

3
China Anti Cancer Drugs Market expected to be US
30 Billion by 2024.
Research Report Title China Cancer Drugs
Market, by Drugs Cytotoxic Drugs
(Antimetabolities, Plant Alkaloids, Alkylating
Agents), Targeted Drugs, Monoclonal Antibiotics,
Hormonal Drugs, Traditional Chinese Medicine
(TCM), Others, Cancer (Lung, Stomach, Breast,
Esophageal, Liver Others), Therapy
(Chemotherapy, Targeted Therapy, Hormonal Therapy
Others), Companies (Merck, Celgene, Eli Lilly,
Roche Sino BioPharma) Access Full
Research  https//www.renub.com/china-cancer-drug
s-market-p.php In China, cancer is a major
public health concern. Several factors are
responsible for the increasing prevalence of
cancer in China such as extensive use of tobacco,
unhealthy lifestyle and rising geriatric
population. Almost one-third of the worlds lung
cancer and nearly half of the liver, stomach and
esophageal cases of cancer occur in China.   

4
China Anti Cancer Drugs Market expected to be US
30 Billion by 2024.
China Cancer Drugs Market is expected to be US
30 Billion by the year 2024. Cancer drugs act at
various levels cancer cells, extracellular
matrix, endothelium, host cells or immune system.
The cancerous cell can be targeted at
the DNA, RNA or protein level. Most available
chemotherapy drugs interact with tumor DNA while
targeted drugs (monoclonal antibodies) and small
molecules directed against proteins. With
increasing incidence of cancer cases in China,
rising per capita income in the region, growing
awareness regarding cancer coupled with improving
healthcare infrastructure and reimbursement on
cancer drugs, it is believed that China Cancer
Drugs Market will certainly touch new leap in the
forthcoming years.    Request a free sample copy
of the report  https//www.renub.com/contactus.ph
p   The decision of using a cancer drug depends
on several factors, including the type of cancer
and the location of the cancer and its stage.
Generally cancer drugs are administered
intravenously however, some cancer medicines can
also be taken orally and others can be
administered intramuscularly or intrathecally

5
China Anti Cancer Drugs Market expected to be US
30 Billion by 2024.

6
China Anti Cancer Drugs Market expected to be US
30 Billion by 2024.
With the advancement in medicinal technology, in
the early 21st century, the identification of
molecular features unique to cancer cells
stimulated the evolution of targeted cancer
therapies, which possess a pretty high degree of
specificity for cancer cells. Today, across the
globe, targeted therapy for cancer treatment is
gaining popularity because targeted therapy are
designed to block the growth and spread of cancer
by interfering with a specific biochemical
pathway central to the development, growth, and
spread of that particular cancer unlike
chemotherapy that act on all rapidly dividing
normal and cancerous cells. Chinese
biopharmaceuticals industry is witnessing a rapid
transformation as the government focuses on an
innovation-driven economic by 2020. In the last
two decades, China has invested a total of 18 of
the worlds spending on Research and Development
(RD) across all sectors. Healthcare sector has
a specific precedence, as the Chinese government
facing dual challenges of improving the health of
the population and maintaining the growth of the
biopharmaceutical industry. Recently, the
government has stepped up its efforts in reducing
the cost of cancer drugs and has eliminated
import tariffs on almost all cancer drugs, so
that the Chinese patients need not have to give
up their treatment. These recent developments
will certainly drive China Cancer Drugs Market in
near future. 

7
China Anti Cancer Drugs Market expected to be US
30 Billion by 2024.
  • Client can Purchase this Report in Sections from
    below link 
  • Access full Research https//www.renub.com/china-
    cancer-drugs-market-p.php
  •  
  • China Anti Cancer Drugs Market Summary
  • On the basis of drugs type Cytotoxic Drugs
    controls the Anti Cancer Drugs Market in China.
    The report is further segmented into Targeted
    Drugs, Monoclonal Antibiotics, Hormonal Drugs,
    TCM and Others. Cytotoxic Drugs is further
    divided into Antimetabolites, Plant Alkaloids and
    Alkylating Agents.  
  • Based on Cancer types, Lung cancer drives the
    China Anti Cancer Drugs Market. The other cancer
    markets studied in the report are as follows
    Lung, Stomach, Breast, Esophageal, Liver
    Others.  
  • On the basis of Therapy type, China Anti Cancer
    Drugs Market is divided into following segments
    Chemotherapy, Targeted Therapy, Hormonal Therapy
    and Others.
  • Companies studied in the report are as follows
    Merck, Celegene, Eli Lilly, Roche, Sino
    BioPharma
  • If the information you seek is not included in
    the current scope of the study kindly share your
    specific requirements with our custom research
    team at 
  • info_at_renub.com


8
Table of Contents for China Anti Cancer Drugs
Market
Key Topics Covered 1. Executive Summary 2.  
 China Cancer Drugs Market 3.    Market Share
China Anti-Cancer Drugs 3.1    By Drugs 3.2  
 By Cancer3.3    By Therapy 4.    Drugs China
Cancer Market 4.1    Cytotoxic Drugs 4.2  
 Targeted Drugs4.3    Monoclonal
Antibiotics 4.4    Hormonal Drugs4.5  
 Traditional Chinese Medicine 4.6    Others 5.  
 Cancer Type Market 5.1    Lung Cancer 5.2  
 Stomach Cancer5.3    Breast Cancer 5.4  
 Esophageal Cancer5.5    Liver Cancer 5.6  
 Others

9
Table of Contents for China Anti Cancer Drugs
Market
6.    Therapy China Cancer Market 6.1  
 Chemotherapy 6.2    Targeted Therapy6.3  
 Hormonal Therapy 6.4    Others 7.    Company
Analysis 7.1    Merck 7.2    Celgene 7.3  
 Eli Lilly 7.4    Roche 7.5    Sino
BioPharma 8.    Growth Drivers 8.1    Growing
Awareness towards Cancer Diagnosis and
Treatment8.2    Increasing Use of Targeted
Therapy8.3    Increasing Research and
Development Activities8.4    Cutting Import
Duties on Cancer Drugs 9.    Challenges 9.1  
 High Cost of Cancer Drugs9.2    Major Side
Effects of Cancer Treatment

10
Get Free Customization in this Report
Drugs Pharmaceuticals Market Reports
https//www.renub.com/drugs-and-pharmaceuticals-
13-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel 1-678-302-0700 Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel 91-120-421-9822 Email info_at_renub.com www.renub.com